Global leader in innovative, implantable hearing solutions selects clinivation WorldView as its most comprehensive, authoritative, and up-to-date resource for building its medical product submissions and registrations worldwide.
Natick, MA, July 28, 2008 – clinivation, Inc. announced today that Cochlear Limited (ASX: COH) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“Cochlear has continued to bring technological innovation to the market for years,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “Cochlear will have access to accurate intelligence from in-country regulatory authorities and Ministries of Health,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Cochlear Limited
Cochlear Limited is an Australia-based technology company offering implantable hearing solution. The Company operates in Americas, Europe and Asia Pacific. During the fiscal year ended June 30, 2007, the Company introduced Baha Intenso, a headworn device with advanced digital signal processing, extra power and reduced size. The Company’s product range includes Freedom Sound Processors, SmartSound, Freedom Implant and Nucleus Freedom. It also offers a range of Nucleus Freedom accessories, such as frequency modulation (FM) connections, personal audio cable, television/stereo cable and monitor earphones. Its wholly owned subsidiaries include Cochlear Sweden Holdings, Cochlear Americas and Cochlear Europe Limited. On January 2, 2007, the Company acquired Cochlear-related manufacturing operations and assets from Crystalaid Manufacture Pty Ltd. On April 30, 2007, it acquired the remaining 25% of shares in Cochlear Acoustics Limited from Phonak AG, making it a wholly owned subsidiary.
For more information, please visit www.cochlear.com.